Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00706290 · ClinicalTrials.gov registry record · Phase 2
Brief CBT for Anxiety and Advanced Cancer
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 49
- Enrollment target
NCT00706290: Completed Phase 2 study, sponsored by Massachusetts General Hospital.
NCT00706290 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00706290, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 49 participants
- Enrollment target
Study Summary
RATIONALE: Providing cognitive-behavioral therapy (CBT) may reduce anxiety and improve quality of life of patients with advanced cancer. PURPOSE: To examine the development and pilot testing of a brief cognitive-behavioral therapy intervention to treat anxiety and improve quality of life in patients with advanced cancer. Hypothesis: Patients with anxiety associated with advanced cancer who receive CBT will report significantly fewer anxiety symptoms compared to those in the comparison condition.
Interventions
- BEHAVIORAL Brief Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2007-04 |
| Est. Completion | 2010-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00706290
The ClinicalTrials.gov registry entry for NCT00706290 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brief Cognitive Behavioral Therapy is the first listed.
NCT00706290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00706290 about?
NCT00706290 is a clinical study titled "Brief CBT for Anxiety and Advanced Cancer". RATIONALE: Providing cognitive-behavioral therapy (CBT) may reduce anxiety and improve quality of life of patients with advanced cancer. PURPOSE: To examine the development and pilot testing of a brief cognitive-behavioral therapy intervention to treat anxiety and improve quality of life in patient...
What is the current status of trial NCT00706290?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2007-04. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00706290?
The interventions under investigation include: Brief Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00706290?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.